Purified anti-BRST-3 Antibody anti-BRST-3 - B72.3,BioLegend,915206

B72.3 is reactive with a broad spectrum of epithelial malignancies in human, including invasive ductal carcinoma, lung carcinomas, ovarian, gastric and colonic adenocarcinomas. It appears to be non-reactive or weakly reactive to most normal tissues.

Host

Mouse

Reactivity

Human

Application

IHC-P - Quality tested

Platform ID

BAB395355869

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-BRST-3 Antibody anti-BRST-3 - B72.3
Cat. No.915206
HostMouse
RRIDAB_2616965 (BioLegend Cat. No. 915206)
IsotypeMouse IgG1, κ
ReactivityHuman
ApplicationIHC-P - Quality tested
ClonalityMonoclonal
Clone NumberB72.3
Concentration0.5 mg/ml
TargetBRST-3
ImmunogenThis antibody was generated against a membrane-enriched fraction of a breast carcinoma metastatic to the liver.
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

BRST-3, also known as TAG-72 (Tumor Associated Glycoprotein-72), a high molecular weight (220-400 kD) glycoprotein complex, is expressed by a wide variety of human adenocarcinomas.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.